Serology

Point of Care – HIV PoCT ONLY

Clinical material provided (Liquid Stabilised Whole blood – 0.4 mL) to assess the detection of HIV using Point of Care Assays

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

HIV PoCT Screening – Ag, HIV PoCT Screening – Ab, HIV PoCT Confirmatory, HIV PoCT Interpretation

Point of Care – Influenza A & B Antigen PoCT ONLY

Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.5 mL) to assess the detection of Influenza antigen using Point of Care Assays

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

Influenza A Antigen PoCT, Influenza B Antigen PoCT

Point of Care – RSV Antigen PoCT ONLY

Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.5 mL) to assess the detection of RSV antigen using Point of Care Assays

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

RSV Antigen PoCT ONLY

Retroviral – HIV serology (comprehensive)

Clinical material provided (Liquid Serum / Plasma – 1.0 mL) to assess the detection of HIV using serological markers

Frequency / Number of samples

6 surveys / 2 samples per survey

Tests

HIV Ag/Ab Combination Screen, HIV Ag/Ab Combination Supplementary, HIV Antibody ONLY Screening, HIV Antibody ONLY Supplementary, HIV-2 Antibody ONLY Supplementary, HIV Antigen ONLY, HIV Antigen ONLY Confirmatory, HIV 1/2 Antibody Confirmatory, HIV 1 Only Antibody Confirmatory, HIV 2 Only Antibody Confirmatory, HIV Interpretation

Retroviral – HTLV serology

Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of HTLV using serological markers

Frequency / Number of samples

6 surveys / 2 samples per survey

Tests

HTLV Antibody Screening, HTLV Antibody Supplementary, HTLV Antibody Confirmatory

Specimen Free Program

Educational tool for staff, presenting case studies and scenarios that may be encountered in serological and molecular testing laboratories

Frequency / Number of samples

5 surveys / 1 case study per survey

Tests

Answers to questions regarding the scenarios presented

Vaccine Preventable – Bordetella pertussis serology

Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Bordetella pertussis using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Bordetella pertussis IgG, Bordetella pertussis IgM, Bordetella pertussis IgA, Bordetella pertussis Toxin & FHA IgG, Bordetella pertussis Toxin & FHA IgM, Bordetella pertussis Toxin & FHA IgA, Bordetella pertussis Toxin IgG, Bordetella pertussis Toxin IgM, Bordetella pertussis Toxin IgA, Bordetella pertussis Interpretation

Vaccine Preventable – Influenza A & B Antibody serology

Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Influenza A & Influenza B using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Influenza A IgG, Influenza A IgM, Influenza A IgA, Influenza A Total Antibody, Influenza A Interpretation, Influenza B IgG, Influenza B IgM, Influenza B IgA, Influenza B Total Antibody, Influenza B Interpretation

Vaccine Preventable – Measles serology

Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Measles using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Measles IgG, Measles IgM, Measles Total Antibody, Measles Interpretation, Measles Confirmatory

Vaccine Preventable – Mumps serology

Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Mumps using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Mumps IgG, Mumps IgM, Mumps Total Antibody, Mumps Interpretation

Vaccine Preventable – Q fever serology

Clinical material provided (Liquid Serum / Plasma – 0.4 mL) to assess the detection of Q Fever using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Q fever Total Antibody, Q fever Phase 1 IgA, Q fever Phase 1 IgG, Q fever Phase 1 IgM, Q fever Phase 1 Total Antibody, Q fever Phase 2 IgA, Q fever Phase 2 IgG IFA, Q Fever Phase 2 IgG EIA, Q fever Phase 2 IgM IFA, Q Fever Phase 2 IgM EIA, Q fever Phase 2 Total Antibody, Q fever Interpretation

Vaccine Preventable – Varicella zoster serology

Clinical material provided (Liquid Serum / Plasma – 0.35 mL)to assess the detection of Varicella zoster virus using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Varicella Zoster IgG, Varicella Zoster IgM, Varicella Zoster Total Antibody, VZ Interpretation